NYSEMKT: OGEN
Oragenics Inc Stock Ownership - Who owns Oragenics?

Insider buying vs selling

Have Oragenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Odyssey Health Inc10% Owner2025-06-185,044$4.26
$21.49kSell
Odyssey Health Inc10% Owner2025-06-172,000$4.46
$8.92kSell
Odyssey Health Inc10% Owner2025-06-165,000$4.45
$22.25kSell
Odyssey Health Inc10% Owner2025-06-135,000$4.27
$21.35kSell
Alan W. DuntonDirector2024-12-0666$0.36
$23.76Sell
Fred TellingDirector2024-12-063,597$0.36
$1.29kSell

1 of 1

OGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OGEN insiders and whales buy or sell their stock.

OGEN Shareholders

What type of owners hold Oragenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk2,776.34%19,874,069$25.84MInsider
Koski Family LP1,373.72%9,833,595$12.78MInsider
Jeffrey D. Hillman458.27%3,280,434$4.26MInsider
Christine L. Koski293.36%2,100,000$2.73MInsider
David Brian Hirsch139.70%1,000,000$1.30MInsider
Robert T. Zahradnik123.07%881,000$1.15MInsider
George T. Hawes104.13%745,397$969.02kInsider
Mento Soponis72.66%520,133$676.17kInsider
John N. Bonfiglio53.82%385,255$500.83kInsider
Bruce A. Cassidy Sr.49.55%354,728$461.15kInsider

1 of 3

OGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OGEN0.26%99.74%Net Selling
AEON4.44%95.56%Net Buying
REVB1.02%98.98%Net Buying
BDRX0.00%0.00%
NCNA0.47%0.00%

Oragenics Stock Ownership FAQ

Who owns Oragenics?

Oragenics (NYSEMKT: OGEN) is owned by 14.71% institutional shareholders, 5,538.63% Oragenics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Oragenics shareholder, owning 19.87M shares representing 2,776.34% of the company. Randal J. Kirk's Oragenics shares are currently valued at $25.04M.

If you're new to stock investing, here's how to buy Oragenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.